FAMBROUGH DOUGLAS 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 13, 2021
Insider Transaction Report
Form 4
FAMBROUGH DOUGLAS
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-10$2.97/sh+33,670$100,000→ 76,834 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-10−146,195→ 55,055 totalExercise: $3.42Exp: 2023-09-24→ Common Stock (146,195 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-10−33,670→ 191,330 totalExercise: $2.97Exp: 2027-01-03→ Common Stock (33,670 underlying) - Exercise/Conversion
Common Stock
2021-12-10$3.42/sh+146,195$499,987→ 223,029 total
Footnotes (2)
- [F1]As of the transaction date, the option was fully vested. The option vested in 48 monthly installments over the four-year period starting on the last day of January 2017.
- [F2]As of the transaction date, the option was fully vested. The option vested 1/48 monthly on last day of each month with a vesting start date of 07/30/2013.